DaTscan

DaTscan is a brand name of ioflupane I 123, approved by the FDA in the following formulation(s):

DATSCAN (ioflupane i-123 - solution; intravenous)

• 
  Manufacturer: GE HLTHCARE INC
  
  Approval date: January 14, 2011
  
  Strength(s): 5MCI/2.5ML (2MCI/ML) ^[RLD]

Has a generic version of DaTscan been approved?

No. There is currently no therapeutically equivalent version of DaTscan available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DaTscan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with DaTscan.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • January 14, 2016 - NEW CHEMICAL ENTITY
  
  

See also...

• DaTscan Consumer Information (Drugs.com)
• DaTscan Consumer Information (Cerner Multum)
• DaTscan Advanced Consumer Information (Micromedex)
• Ioflupane I-123 Consumer Information (Cerner Multum)
• Ioflupane i 123 Intravenous Advanced Consumer Information (Micromedex)